Cordelia Schiene-Fischer

Title: Cordelia Schiene-Fischer: Innovator in Peptide Chemistry

Introduction

Cordelia Schiene-Fischer is a prominent inventor based in Halle, Germany. She has made significant contributions to the field of peptide chemistry, particularly in the area of catalysis. Her innovative work has implications for pharmaceutical applications and understanding pathophysiological processes.

Latest Patents

Cordelia holds a patent for the "Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds." This invention is based on the discovery that the cis/trans isomerisation of secondary amide peptide bonds in oligo- and polypeptides can be catalytically promoted. The catalysis is facilitated by enzymes known as 'secondary amide peptide bond cis/trans isomerases (APIases).' The APIase activity is believed to play a crucial role in various pathophysiological processes. Consequently, her invention also relates to pharmaceutical compositions that include substances inhibiting APIase activity. Cordelia has 1 patent to her name.

Career Highlights

Cordelia Schiene-Fischer is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., a leading research institution in Germany. Her work at this prestigious organization has allowed her to explore and develop her innovative ideas in peptide chemistry.

Collaborations

Throughout her career, Cordelia has collaborated with notable colleagues, including Gerhard Küllertz and Gunter Fischer. These collaborations have enriched her research and contributed to advancements in her field.

Conclusion

Cordelia Schiene-Fischer is a trailblazer in peptide chemistry, with her innovative patent contributing to the understanding of secondary amide peptide bonds. Her work has the potential to impact pharmaceutical developments significantly.